SearchDictionaryMobileLogin

Stephen J Freedland Selected Research

Obesity

09/2008Obesity and positive surgical margins by anatomic location after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database.
09/2008Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
11/2007Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.
05/2007Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database.
02/2006Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection.
11/2005Obesity and capsular incision at the time of open retropubic radical prostatectomy.
09/2005Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center.
06/2005Obesity does not adversely affect health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy.
04/2005Stronger association between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 years.
08/2004Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins.
02/2004Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group.

Articles by Research Topic

Disease

23Prostatic Neoplasms (Prostate Cancer)
09/2008 - 04/2003
11Obesity
09/2008 - 02/2004
7Neoplasms (Cancer)
08/2008 - 02/2002
1Carcinoma (Carcinomatosis)
12/2003
1Pain (Aches)
06/2003
1Renal Cell Carcinoma (Grawitz Tumor)
01/2003

Drug/Important Bio-Agent (IBA)

11Prostate-Specific Antigen (Semenogelase)IBA
09/2008 - 02/2002
1Insulin (Novolin)FDA Link
01/2008
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2006
1Dinoprostone (PGE2)FDA Link
08/2006
1HormonesIBA
06/2003
1Neprilysin (Neutral Endopeptidase)IBA
04/2003

Therapy/Procedure

27Prostatectomy (Retropubic Prostatectomy)
09/2008 - 02/2002
2Nephrectomy
06/2003 - 01/2003
1Chemoprevention
05/2008
1Hemodilution
11/2007
1Drug Therapy (Chemotherapy)
01/2005
1Fat-Restricted Diet (Diet, Fat Restricted)
02/2004
1Heterologous Transplantation (Xenotransplantation)
02/2004
1Lymph Node Excision (Lymph Node Dissection)
01/2003